The main objective of the National Focal Point is to collect, to produce, to analyze and to provide valid, reliable and comparable data on drugs and drug addiction in Luxembourg. This includes surveillance and research activities.
The National Focal Point (NFP) of the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) is qualified in surveillance and research activities around the collection, analysis, and provision of reliable and comparable data on drugs and drug addiction in Luxembourg.
NFPs are expert centers, constantly evolving to meet emerging needs, follow trends, and develop drug-related research.
The NFP operates both at the national and international level and is
co-financed by the Ministry of Health and the EMCDDA on a contractual
basis. Activities include coordination of national information networks in order to meet the EMCDDA’s requirements for a core set of data, maintaining the national drug surveillance system “RELIS”, editing annual reports on the state of drug-related problems at the national level, and conduction of targeted research projects.
At a national level, the priorities of the NFP are to collect, process and compile relevant and reliable information on drugs and drug addiction. At the international level, the following core issues are part of the NFPs contributions to the EMCDDA:
• Prevalence and patterns of drug use among the general population
• Problem drug use and demand for treatment
• Drug-related morbidity (e.g. infectious diseases) and mortality
• Drug-related crime, markets, and supply data
• Public expenditures dedicated to the fight against drugs
• Actions on new drugs and emerging trends
The National European Monitoring Centre for Drugs and Drug addiction – Luxembourg Focal Point has been set up in 1994 and implemented within the CRP-Santé in 2000. It operates both at national and international level and is co-financed by the Ministry of Health and the EMCDDA on a contractual basis. Each of the 27 EU Member states (plus Norway and the candidate countries) run a NFP and thus are part of a wider network called REITOX.
National Focal Points are expert centers, constantly developing to meet emerging needs and follow up trends. Common activities of a NFP include coordinating national information networks in order to meet the EMCDDA’s requirements for a core set of data and to edit annual reports on the state of drugs problem at the national level.
The EMCDDA – Luxembourg Focal Point is under the direction of Alain Origer who holds dual positions as Head of the Luxembourg Focal Point of the EMCDDA and National Drug Coordinator for the Ministry of Health. With a foundation and expertise in psychoanalytic therapy, Alain Origer has led his unit through numerous drug-related surveillance and research studies, nationally and throughout Europe. The results of his research and surveillance efforts have been widely published in international, peer-reviewed medical journals, as well as in publications for local and foreign government health agencies.
For more information please visit the EMCDDA website:
Current Team Members :
Statistic bulletin RELIS 2009_french version (448.03 kB)
Summary RELIS report 2008_english version (72.83 kB)
Statistic bulletin RELIS 2008_french version (490.06 kB)